| 2019-03-04 | The DESiGN trial (DEtection of Small for Gestational age Neonate), evaluating the effect of the Growth Assessment Protocol (GAP): Study protocol for a randomised controlled trial | Vieira, MC; Relph, S; Copas, A; Healey, A; Coxon, K; Alagna, A; Briley, A; Johnson, M; Lawlor, DA; Lees, C; Marlow, N; McCowan, L; Page, L; Peebles, D; Shennan, A; Thilaganathan, B; Khalil, A; Sandall, J; Pasupathy, D; Brocklehurst, P; Tebbs, S; Doré, C; Seed, P; Delaney, L; Cresswell, J; Petty, S; Ajay, B; Wright, B; O'Donnell, H; Howard, M; Wayman, E; Galea, P; Dhanjal, M; Iaschi, E; Hodge, V; Samarage, H; Chita, S; Napolitano, R; Tsikimi, I; Ghalustians, F; Bakalis, S; Cicero, S; Peregrine, E; Smith, L; Janga, D; Hutt, R; Chandraharan, E |
